Kate T.

Kate T. has extensive work experience in the clinical operations field. Kate started their career in 2008 at Site and Industry, where they worked in various roles related to clinical operations for ten years. In 2018, they joined ArQule U.K. Ltd as an Associate Director of Clinical Operations and Program Management. Kate later became a Director of Clinical Operations at the same company. In 2020, Kate joined Kiniksa Pharmaceuticals as a Director of Clinical Operations for a brief period before transitioning to Foghorn Therapeutics, Inc. as a Director of Clinical Operations. In 2021, they moved to Black Diamond Therapeutics, initially as a Director of Clinical Operations before being promoted to Senior Director. Most recently, they joined Dyne Therapeutics in 2023 as an Executive Director and Head of Clinical Operations.

Kate T. has a Master of Public Health degree (MPH) from Boston University School of Public Health, which they completed in 2008. Prior to that, they obtained a Bachelor of Arts degree (BA) from Connecticut College, with a focus on Liberal Arts and Sciences. Kate's earlier education history includes attending Holderness School, but no specific degrees or fields of study were provided for that period.